Gritstone Bio Inc (NASDAQ: GRTS) kicked off on Friday, up 13.57% from the previous trading day, before settling in for the closing price of $0.48. Over the past 52 weeks, GRTS has traded in a range of $0.42-$3.33.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 230.33% over the past five years. While this was happening, its average annual earnings per share was recorded 24.88%. With a float of $110.21 million, this company’s outstanding shares have now reached $118.11 million.
Let’s look at the performance matrix of the company that is accounted for 231 employees. In terms of profitability, gross margin is -325.12%, operating margin of -8786.76%, and the pretax margin is -7825.47%.
Gritstone Bio Inc (GRTS) Insider Updates
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Gritstone Bio Inc is 6.69%, while institutional ownership is 30.00%. The most recent insider transaction that took place on May 16 ’24, was worth 18,156. In this transaction PRESIDENT AND CEO of this company sold 24,263 shares at a rate of $0.75, taking the stock ownership to the 985,360 shares. Before that another transaction happened on May 16 ’24, when Company’s EVP, CHIEF OPERATING OFFICER sold 13,749 for $0.75, making the entire transaction worth $10,288. This insider now owns 359,293 shares in total.
Gritstone Bio Inc (GRTS) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around 24.88% per share during the next fiscal year.
Gritstone Bio Inc (NASDAQ: GRTS) Trading Performance Indicators
Take a look at Gritstone Bio Inc’s (GRTS) current performance indicators. Last quarter, stock had a quick ratio of 2.54. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 130.06.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.15, a number that is poised to hit -0.19 in the next quarter and is forecasted to reach -0.89 in one year’s time.
Technical Analysis of Gritstone Bio Inc (GRTS)
Gritstone Bio Inc (NASDAQ: GRTS) saw its 5-day average volume 0.7 million, a negative change from its year-to-date volume of 2.09 million. As of the previous 9 days, the stock’s Stochastic %D was 78.61%. Additionally, its Average True Range was 0.04.
During the past 100 days, Gritstone Bio Inc’s (GRTS) raw stochastic average was set at 21.06%, which indicates a significant decrease from 96.10% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 72.78% in the past 14 days, which was lower than the 81.97% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.5535, while its 200-day Moving Average is $1.3541. Nevertheless, the first resistance level for the watch stands at $0.5777 in the near term. At $0.6047, the stock is likely to face the second major resistance level. The third major resistance level sits at $0.6536. If the price goes on to break the first support level at $0.5018, it is likely to go to the next support level at $0.4529. Assuming the price breaks the second support level, the third support level stands at $0.4259.
Gritstone Bio Inc (NASDAQ: GRTS) Key Stats
The company with the Market Capitalisation of 65.03 million has total of 108,569K Shares Outstanding. Its annual sales at the moment are 16,340 K in contrast with the sum of -138,490 K annual income. Company’s last quarter sales were recorded 920 K and last quarter income was -23,400 K.
